🇺🇸 FDA
Pipeline program

Neoadjuvant Chemotherapy

XYURO001

Phase 2 small_molecule completed

Quick answer

Neoadjuvant Chemotherapy for High-Grade Upper Tract Urothelial Carcinoma is a Phase 2 program (small_molecule) at Xiangya Hospital of Central South University with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiangya Hospital of Central South University
Indication
High-Grade Upper Tract Urothelial Carcinoma
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials